Catalent Launches Technology For Softgel Innovation
To Aid Formulation And Manufacture Of Delayed/Enteric Capsules
Catalent has announced the launch of a new technology, OptiGel DR, for the formulation and manufacture of delayed/enteric release softgels, offering advantages such as potentially enhancing bioavailability and reducing gastric reflux effects.
